CEACAM5 and neoplasm: Furthermore, a non-lethal radiotherapy dosage increases surface expression of first apoptosis signal (Fas) ligand, carcinoembryonic antigen, and major histocompatibility complex I (MHCI) on tumor cells, enabling tumor-specific CD8+ T cells to recognize the tumor cells and exert their cytotoxic effects.142